Literature DB >> 9696820

Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.

N Cueille1, R Nougarede, F Mechali, M Philippe, C Bonne-Andrea.   

Abstract

We have found that the replicative helicase E1 of bovine papillomavirus type 1 (BPV-1) interacts with a key cell cycle regulator of S phase, the cyclin E-Cdk2 kinase. The E1 helicase, which interacts with cyclin E and not with Cdk2, presents the highest affinity for catalytically active kinase complexes. In addition, E1, cyclin E, and Cdk2 expressed in Xenopus egg extracts are quantitatively coimmunoprecipitated from crude extracts by either anti-Cdk2 or anti-E1 antibodies. E1 protein is also a substrate of the cyclin E-Cdk2 kinase in vitro. Using the viral components required for in vitro BPV-1 replication and free-membrane cytosol from Xenopus eggs, we show that efficient replication of BPV plasmids is dependent on the addition of E1-cyclin E-Cdk2 complexes. Thus, the BPV initiator of replication and cyclin E-Cdk2 are likely to function together as a protein complex which may be the key to the cell cycle regulation of papillomavirus replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696820      PMCID: PMC109948     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases.

Authors:  Z X Xiao; D Ginsberg; M Ewen; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

2.  Expression cloning of Siamois, a Xenopus homeobox gene expressed in dorsal-vegetal cells of blastulae and able to induce a complete secondary axis.

Authors:  P Lemaire; N Garrett; J B Gurdon
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

3.  The bovine papillomavirus E1 protein alters the host cell cycle and growth properties.

Authors:  M Belyavskyi; J Miller; V Wilson
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

4.  Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein.

Authors:  T A Zanardi; C M Stanley; B M Saville; S M Spacek; M R Lentz
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

5.  Bovine papillomavirus type 1 DNA replication: the transcriptional activator E2 acts in vitro as a specificity factor.

Authors:  C Bonne-Andréa; F Tillier; G D McShan; V G Wilson; P Clertant
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.

Authors:  J Y Su; R E Rempel; E Erikson; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Early events in DNA replication require cyclin E and are blocked by p21CIP1.

Authors:  P K Jackson; S Chevalier; M Philippe; M W Kirschner
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

8.  Cellular factors required for papillomavirus DNA replication.

Authors:  T Melendy; J Sedman; A Stenlund
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Functional analysis of pRb2/p130 interaction with cyclins.

Authors:  P P Claudio; A De Luca; C M Howard; A Baldi; E J Firpo; A Koff; M G Paggi; A Giordano
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

10.  Xenopus cyclin E, a nuclear phosphoprotein, accumulates when oocytes gain the ability to initiate DNA replication.

Authors:  S Chevalier; A Couturier; I Chartrain; R Le Guellec; C Beckhelling; K Le Guellec; M Philippe; C C Ford
Journal:  J Cell Sci       Date:  1996-06       Impact factor: 5.285

View more
  30 in total

1.  Surface mutagenesis of the bovine papillomavirus E1 DNA binding domain reveals residues required for multiple functions related to DNA replication.

Authors:  Stephen Schuck; Arne Stenlund
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase.

Authors:  Chiung-Yueh Hsu; Francisca Mechali; Catherine Bonne-Andrea
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

3.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

5.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

7.  Maternal Wnt/STOP signaling promotes cell division during early Xenopus embryogenesis.

Authors:  Ya-Lin Huang; Zeinab Anvarian; Gabriele Döderlein; Sergio P Acebron; Christof Niehrs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-21       Impact factor: 11.205

8.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

9.  Functional mapping of the DNA binding domain of bovine papillomavirus E1 protein.

Authors:  M West; D Flanery; K Woytek; D Rangasamy; V G Wilson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 10.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.